Did your company pay for employee prescriptions between 2009 and 2019?
$533 million in court-approved settlements is set aside right now. Most eligible companies never claim their share.
See if your company qualifies
Four fields. A claims specialist reviews your organization and responds within one business day with a straight answer on eligibility.
"*" indicates required fields
Is your organization eligible?
If you paid for or reimbursed generic prescription drugs between 2009 and 2019, you may be a settlement class member.
- Self-funded employers
- Insurers and health plans
- Union benefit plans
- Third-party payors and TPAs
Not sure? That's what we're here for.
Eligibility turns on which drugs you covered, when, and through which plan. Answering that from the public notices alone is a research project.
Send us four details and we'll tell you where you stand — at no cost, before you commit to anything.
How Macmoor represents you
Nobody mails you a check. The money moves only if a complete, accurate claim is filed before the deadline.
We assess eligibility
You give us your company name, EIN and plan type. We check your organization against the certified settlement classes and the eligible drug list.
We build the claim
If you qualify, we sign a limited claims-management agreement and assemble the pharmacy and payment records the administrator requires.
We track it to payment
We file, respond to administrator queries, and follow the claim through to distribution — then disburse your recovery.
Nothing out of pocket
Macmoor is paid 25% of what you recover — and nothing if you recover nothing.
Important Disclosures
Disclaimer: The claims filing deadline is November 9th 2026. Macmoor Capital is an independent third-party claims management firm. We are not Attorneys, We are not affiliated with the Court, the Claims Administrator, or Class Counsel. You do not need to sign up with a third-party claims recovery service provider (like Macmoor Capital) to file a claim for settlement benefits and you do not need to pay a share of your settlement recoveries to any provider. Claimants may file for settlement benefits directly at no cost. For more information please visit our website (www.macmoor.com) or the official court approved settlement website for this case www.GenericDrugsEndPayerSettlement.com, where you can register to be notified when the claims process begins. You may also call the Settlement Administrator at 1-877-316-0171 or email info@GenericDrugsEndPayerSettlement.com.
About the litigation. These settlements stem from a federal antitrust class action, In re Generic Pharmaceuticals Pricing Antitrust Litigation, Case No. 16-MD-2724, in the U.S. District Court for the Eastern District of Pennsylvania. End-payers — consumers, insurers, employer health plans and other entities that paid for or reimbursed generic prescription drugs — alleged that a group of generic drug manufacturers colluded to inflate prices of certain generic medications sold in the U.S. from May 1, 2009 through December 31, 2019. A settlement class has been certified for each end-payer settlement approved by the court. Class definitions and the full list of eligible drugs appear in the settlement notices posted at www.GenericDrugsEndPayerSettlement.com.
Settlement classes to date. Sandoz / Fougera — resolves end-payer antitrust claims against Sandoz and Fougera through a cash fund of approximately $275M, with no admission of wrongdoing. Apotex / Heritage — resolves claims against Apotex for approximately $48 million and Heritage Pharmaceuticals for $10 million, payable to third-party payors. Sun / Taro — resolves end-payer claims against Sun Pharmaceutical Industries and Taro Pharmaceuticals through a $200 million settlement fund payable to consumers and third-party payors.
Claimant outreach. Macmoor Capital works only with corporate and institutional end-payers, including self-funded employers, insurers, union benefit plans, third-party payors, health plans and similar business entities. Macmoor Capital does not solicit individuals.
Read the full Claims Management Agreement
AGREEMENT WITH MACMOOR CAPITAL, LLC FOR CLAIMS MANAGEMENT, RE: GENERIC PHARMACEUTICALS ANTITRUST SETTLEMENTS
- Parties and Term. This Agreement becomes effective on the date it is digitally or manually signed by both the Client identified below ("Client"), and Macmoor Capital ("MMC") and expires six months after final payout of the last settlement payment to any class member in the case captioned In Re: GENERIC PHARMACEUTICALS ANTITRUST LITIGATION, No 16-MD-2724 U.S.D.C, E.D. Pa. (the "Matter").
- Scope of Limited Agency Relationship. Client authorizes MMC to act as its claims management agent for purposes of preparing and submitting claims with full authority to prepare and submit to the court all of Client's present and future claims related to the Matter.
- Duties. MMC will make all reasonable efforts to manage and file complete and accurate claims on behalf of Client, using any and all information provided to MMC by Client, and to secure payment of any share of the settlement proceeds to which client may be entitled in the Matter (such payment as well as any other payment to which Client may be entitled in connection with the Matter, the "Payment"). Although the Client may file claims on its own behalf, it instead elected to engage MMC under the terms of this Agreement to file any and all claims for the Client in relation to the Matter.
- Client to Provide Information and Records. Client shall cooperate with MMC to provide any and all available documentation or information that may be necessary to complete the claims process.
- Distribution of Recovery and Payment of Compensation. Client authorizes MMC to receive settlement proceeds on its behalf for the limited purpose of processing and disbursing such funds to Client, net of MMC's Fee (as defined below). MMC will deposit all claim proceeds, if any, into a dedicated segregated bank account, and disburse to the Client its recovery less the Fee, which will be retained by MMC. If Client receives any portion of the Payment directly, Client will pay MMC the Fee within ten days of its receipt of the Payment.
- MMC Is Not Claimant's Attorney and Is Not Practicing Law. MMC is not a law firm and is not providing the Client with legal advice or legal representation. Client had a reasonable opportunity to consult with its own counsel prior to signing this Agreement. MMC is an independent claims management firm and is not affiliated with the Court, Class Counsel or the Class Administrator.
- Construction and Jurisdiction. This Agreement shall be construed in accordance with the laws of the State of Florida applicable to contracts wholly made and performed therein. Any dispute under or relating to this Agreement shall be resolved by arbitration before a single arbitrator, in Palm Beach County, FL, under the rules of the American Arbitration Association. The arbitrator shall render a written decision and shall award the prevailing party its attorney's fees and costs in each such proceeding.
- Confidentiality. The information about the Client provided to MMC pursuant to this Agreement is and shall remain the confidential and proprietary information of the Client. MMC will use such information solely for the purpose of filing claims on behalf of the Client in the Matter, and not for any other purpose. Upon expiration of the Term and payment for services rendered, MMC will destroy any and all information about the Client except for one archival copy that it may keep for its records.
- Multiple Entities and Locations (If Applicable). This Agreement shall cover the Client, all of its subsidiaries, affiliates, any related entities and all locations. If there is more than one entity associated with this claim, they will be listed in Schedule A, attached hereto and made a part thereof. Although Schedule A may not reflect a full and complete list of the Client's subsidiaries, affiliates and/or related entities, all entities bound by this agreement include, but are not limited to, those listed therein.
- Claimant Outreach. Client acknowledges that MMC works only with corporate and institutional end-payers, including self-funded employers, insurers, union benefit plans, third party payors, health plans and similar business entities. MMC does not solicit individuals.
- Compensation. In consideration of the performance of the duties set forth in this Agreement, Client shall pay MMC 25% (twenty five percent) of the Payment (the "Fee"). MMC shall be entitled to retain its Fee from all sums received by MMC on behalf of Client.
By signing this document, you represent that you have the authority to enter into this Agreement. Entity schedules, authorized-signer details and digital signature are collected on the secure signing page once eligibility is confirmed.